Clinical validation of the CD32b biomarker on the European market

Katherine L B Borden

Molecular Mechanisms of eIF4E mediated transformation

Leukaemia

Hematology and hematologic malignancies Pathology

Kapil Bhalla

Novel Targeted Therapy for AML

Leukaemia

Andrew G Myers

Synthesis and Study of Natural and Non-natural Antiproliferative Agents

Multiple myeloma and immunoproliferative diseases Leukaemia

Hematology and hematologic malignancies Pathology

Christopher I Li

Pediatric Oncology Research Training Program

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Pediatric oncology or childhood cancer

Robert M Williams

Multiple Myeloma and Cancer Therapies via Largazole Analogs

Multiple myeloma and immunoproliferative diseases Leukaemia

Hematology and hematologic malignancies Pathology

Martine Extermann

Decision Models to Compare Treatments in Older Patients with AML

Leukaemia

Hematology and hematologic malignancies

Alan Rein

Retrovirus Assembly and Maturation – Rockville

Leukaemia

Hematology and hematologic malignancies Pathology

Global Noncommunicable Diseases Intiatives

Bilateral collaboration with Tunisia

Leukaemia

Jerald Patrick Radich

The Genetics of Post-Transplant Relapse in Myeloid Malignancy

Leukaemia

Pathology